David Rosenbaum - Sep 13, 2024 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Development Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
Stock symbol
ARDX
Transactions as of
Sep 13, 2024
Transactions value $
-$33,254
Form type
4
Date filed
9/16/2024, 06:14 PM
Previous filing
Aug 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Sale -$33.3K -5.31K -3.34% $6.26 154K Sep 13, 2024 By Wife F1, F2, F3
holding ARDX Common Stock 77.6K Sep 13, 2024 Family Trust F4
holding ARDX Common Stock 352K Sep 13, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was executed in multiple trades in prices ranging from $6.2601 to $6.265, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote
F2 Reflects the adjusted total which includes the purchase of 2,676 shares under the Ardelyx Employee Stock Purchase Plan in August 2024.
F3 The shares are directly held by the Reporting Person's wife.
F4 The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.